Abstract
Tracing potential biomarkers through proteomics has been further developed and is nearing realization. The whole sequence of human proteome is becoming better understood with the passage of time. However, it is a long way to go to pinpoint biomarker proteins out of complex biofluids and use them for clinical diagnosis, prognosis, and therapeutic applications. From that point of view, the high hopes put in proteomics have not been fulfilled yet. The key reasons for that is the complexity of the proteome and the limited technologies in terms of specificity and reproducibility. Thus, major focus is put on the development of novel innovative analytical techniques in the field of life science, using high-performance single- and multidimensional separation and enrichment methods, such as solid-phase extraction (SPE), liquid chromatography (HPLC), or capillary electrophoresis (CE) coupled to mass spectrometry (MS). A newly emerged technology, termed as material-enhanced laser desorption/ionization (MELDI) meets basic requirements and is applied to reduce the complexity of proteomic samples while liquid chromatography (LC) is used for separation and fractionation, followed by identification with MS/MS including database searching analysis. Different MELDI carriers are employed as support materials to specifically bind peptides and proteins from biofluids like serum or urine. The MELDI approach supports automated routine analysis by means of liquid handling robots for high-throughput applications leading to higher reproducibility, crucial for a successful identification of disease markers with MALDI-TOF MS. Such promising new methods and further technical developments will be necessary to answer the high-wrought expectations on the field of proteomics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Petricoin EE, Paweletz CP, Liotta LA (2002) Clinical applications of proteomics: proteomic pattern diagnostics. J Mammary Gland Biol Neoplasia 7(4):433–440
Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48(8):1296–1304
Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ (2007) Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl 1(1):73–88
Tan CS, Ploner A, Quandt A, Lehtioe J, Pawitan Y (2006) Finding regions of significance in SELDI measurements for identifying protein biomarkers. Bioinformatics 22:1515–1523
Hutchens TW, Yip TT (1993) New desorption strategies for the mass-spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7:576–580
Issaq HJ, Veenstra TD, Conrads TP, Felschow D (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292:587–592
Merchant M, Weinberger SR (2000) Recent advancements in surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Electrophoresis 21:1164–1177
Abramovitz M, Leyland JB (2006) A systems approach to clinical oncology: focus on breast cancer. Proteome Sci 4:1–15
Feuerstein I, Najam-ul-Haq M, Rainer M et al (2006) Material-enhanced laser desorption/ionization (MELDI) – a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysis. J Am Soc Mass Spectrom 17(9):1203–1208
Najam-ul-Haq M, Rainer M, Trojer L, Feuerstein I, Vallant RM, Huck CW et al (2007) Alternative profiling platform based on MELDI and its applicability in clinical proteomics. Expert Rev Proteomics 4(4):447–452
Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics, 2004. CA Cancer J Clin 54(1):8–29
Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145(5):907–923
Pannek J, Partin AW (1998) The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer. Semin Urol Oncol 16(3):100–105
Feuerstein I, Rainer M, Bernardo K et al (2005) Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling. J Proteome Res 4(6):2320–2326
Trojer L, Lubbad SH, Bisjak CP, Wieder W, Bonn GK (2007) Comparison between monolithic conventional size, microbore and capillary poly(p-methylstyrene-co-1,2-bis(p-vinylphenyl)ethane) high-performance liquid chromatography columns: Synthesis, application, long-term stability and reproducibility. J Chromatogr A 1146(2):216–224
Acknowledgments
This work was supported by the Austrian Genome Program (Gen-AU), Vienna, Austria, and by the Project of the Austrian-Chinese Biomarker Platform, Ministry of Science and Research, Vienna. The authors would like to thank PhyNexus Inc. (San Jose, CA, USA) for cooperation regarding the automation process and the Department of Urology (Medical University Innsbruck, Austria) for providing serum samples.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Rainer, M., Sajdik, C., Bonn, G.K. (2013). Mass Spectrometric Profiling of Low-Molecular-Weight Proteins. In: Bäckvall, H., Lehtiö, J. (eds) The Low Molecular Weight Proteome. Methods in Molecular Biology, vol 1023. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7209-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7209-4_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7167-7
Online ISBN: 978-1-4614-7209-4
eBook Packages: Springer Protocols